$BROS stock has now risen 16% today, according to our price data from Polygon. There has been approximately $48,172,291 of trading volume.
It has been the 391st most-searched ticker on Quiver Quantitative over the last day, out of 10,724 total tickers searched.
Here is what we see in our data on $BROS (you can track the company live on Quiver's $BROS stock page):
$BROS Insider Trading Activity
$BROS insiders have traded $BROS stock on the open market 68 times in the past 6 months. Of those trades, 0 have been purchases and 68 have been sales.
Here’s a breakdown of recent trading of $BROS stock by insiders over the last 6 months:
- TRAVIS BOERSMA (Executive Chairman of Board) has made 0 purchases and 34 sales selling 5,000,000 shares for an estimated $301,852,984.
- TRUST AGGREGATOR, LLC DM has made 0 purchases and 17 sales selling 3,069,572 shares for an estimated $185,311,894.
- INDIVIDUAL AGGREGATOR, LLC DM has made 0 purchases and 17 sales selling 1,930,428 shares for an estimated $116,541,090.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BROS Hedge Fund Activity
We have seen 279 institutional investors add shares of $BROS stock to their portfolio, and 247 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,185,156 shares (+1200.7%) to their portfolio in Q3 2025, for an estimated $166,711,065
- D. E. SHAW & CO., INC. removed 2,528,309 shares (-59.8%) from their portfolio in Q3 2025, for an estimated $132,331,693
- CITADEL ADVISORS LLC added 1,967,236 shares (+618.5%) to their portfolio in Q3 2025, for an estimated $102,965,132
- WESTFIELD CAPITAL MANAGEMENT CO LP added 1,779,616 shares (+inf%) to their portfolio in Q4 2025, for an estimated $108,948,091
- BALYASNY ASSET MANAGEMENT L.P. added 1,203,338 shares (+196.0%) to their portfolio in Q3 2025, for an estimated $62,982,710
- MACQUARIE GROUP LTD removed 1,034,472 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $63,330,375
- UBS GROUP AG added 747,626 shares (+33.3%) to their portfolio in Q4 2025, for an estimated $45,769,663
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BROS Revenue
$BROS had revenues of $443.6M in Q4 2025. This is an increase of 29.41% from the same period in the prior year.
You can track BROS financials on Quiver Quantitative's BROS stock page.
$BROS Analyst Ratings
Wall Street analysts have issued reports on $BROS in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 02/13/2026
- Keybanc issued a "Overweight" rating on 12/17/2025
- Mizuho issued a "Outperform" rating on 12/04/2025
- Morgan Stanley issued a "Overweight" rating on 10/22/2025
- Barclays issued a "Overweight" rating on 10/22/2025
- Wells Fargo issued a "Overweight" rating on 10/16/2025
- RBC Capital issued a "Outperform" rating on 09/24/2025
To track analyst ratings and price targets for $BROS, check out Quiver Quantitative's $BROS forecast page.
$BROS Price Targets
Multiple analysts have issued price targets for $BROS recently. We have seen 12 analysts offer price targets for $BROS in the last 6 months, with a median target of $76.5.
Here are some recent targets:
- Andrew M. Charles from TD Cowen set a target price of $73.0 on 02/13/2026
- Jon Tower from Citigroup set a target price of $82.0 on 01/26/2026
- Brian Harbour from Morgan Stanley set a target price of $82.0 on 01/20/2026
- Jeffrey Bernstein from Barclays set a target price of $76.0 on 01/07/2026
- Eric Gonzalez from Keybanc set a target price of $77.0 on 12/17/2025
- Nick Setyan from Mizuho set a target price of $80.0 on 12/04/2025
- Logan Reich from RBC Capital set a target price of $80.0 on 12/03/2025
You can track data on $BROS on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.